Covid-19 Vaccines
For the 2025-2026 El Dorado TrueCare Pharmacy will be offering 2 types of Covid-19 Vaccine: mNEXSPIKE AND SPIKEVAX by Moderna.
|
|
mNEXSPIKE |
SPIKEVAX |
|
Target |
Codes for only two parts of the spike protein; more targeted |
Codes for the entire spike protein |
|
Dose Size |
A smaller, more focused dose of 10mcg |
A larger dose, 50mcg for patients 12 years + |
|
Relative Efficacy |
In a clinical trial, mNEXSPIKE showed 9.3% greater relative efficacy than SPIKEVAX in adults. This increased to 13.5% in those over 65. |
The original vaccine proved highly effective in preventing severe COVID-19. |
|
Approved Population |
Primarily approved for high-risk individuals and seniors: |
Approved for a much wider population: |
|
Side Effects |
Lower rates of local adverse reactions such as pain, swelling and redness at the injection site. Systemic adverse reactions such as fatigue, headache, chills and fever were comparable to SPIKEVAX |
Higher rates of local adverse reactions. Systemic adverse reactions were similar to mNEXSPIKE |
* If you are between the ages of 12-64 years of age you will need to attest to at least one underlying condition as defined by the CDC.
Click HERE for Up-to-Date Covid-19 Vaccination Recommendations!
Spikevax and mnexspike by Moderna 25-26 COVID-19 VACCINE (Age 12+) |
Underlying Conditions and Higher Risk for Severe COVID-19 For patients 12-64 you will be asked to attest to one of the following conditions.
|
Looking For A Rapid Test? |
